论文信息 - Compounded Bioidentical Hormone Therapy: The National Academies Weigh In. - 字舞流文

Compounded Bioidentical Hormone Therapy: The National Academies Weigh In.

J. Manson | C. Stuenkel

[1] D. Mattison,et al. The Clinical Utility of Compounded Bioidentical Hormone Therapy , 2020 .

[2] J. Manson,et al. Menopausal Hormone Therapy. , 2019, JAMA.

[3] S. R. Slaughter,et al. Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance , 2017, Menopause.

[4] J. Manson,et al. Compounded Bioidentical Hormone Therapy: Does the Regulatory Double Standard Harm Women? , 2017, JAMA internal medicine.

[5] J. Manson,et al. The 2017 hormone therapy position statement of The North American Menopause Society , 2017, Menopause.

[6] J. Pinkerton. The 2017 hormone therapy position statement of The North American Menopause Society. , 2017, Menopause.

[7] G. Braunstein,et al. Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement. , 2016, The Journal of clinical endocrinology and metabolism.

[8] Lewis H Kuller,et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. , 2013, JAMA.